keyboard_arrow_leftBack FInderkeyboard_arrow_right

FAB

Supplier

615668575

regulatory@revoxb77.com

Headquarter

Traianovi Vrata 5, Strelbishte, Bureau 1, 1408 Sofia Bulgarie


Activity
REVOX B77 is a company dedicated to the production and marketing of cosmetic products, primarily focused on skin and hair care. Its focus is on offering affordable and effective solutions for the most common skin needs, developing formulas with proven and potent active ingredients aimed at hydration, renewal, protection, and treatment of various skin conditions.


History
Revox B77 is a family-owned company with a long tradition of producing cosmetic products. Inspired by the philosophy of delivering professional results in the comfort of your home, they have created affordable and easy-to-use skincare products. They carefully select raw materials, packaging, and manufacturing facilities from leading European companies, paying attention to every detail to ensure customer satisfaction. Listening to customers is a key motivation in the development of their product ranges, following trends and offering customized solutions for every skincare need.


Product types
The company offers a wide range of skin and hair care products. Its lines include serums, moisturizers, chemical exfoliants (AHA, BHA, PHA), facial oils, antioxidants, sunscreens, anti-aging products, eye contour treatments, and hair reconstruction systems (REVOX B77 PLEX). Highlights include the retinol serum, hyaluronic acid, vitamin C, niacinamide, and salicylic acid, and the complete REVOX B77 PLEX hair restoration system.


Mission
REVOX B77's mission is to create affordable yet effective skincare solutions, enabling everyone to access high-quality self-care products. Its purpose is to improve the health and appearance of skin by helping to treat various skin concerns and allowing users to create personalized routines. Its vision is to be a leader in the industry, combining innovation, effectiveness, and accessibility, while promoting sustainable and cruelty-free practices.


Information reviewed in July 2025